Johnson & Johnson (NYSE:JNJ) could reportedly be on the hook again for the metal-on-metal hip implants it pulled from the market in 2010, this time in India and for much less than it’s cost the company elsewhere. The world’s second-largest medical device maker has fielded numerous lawsuits about its ASR metal-on-metal hip replacement since it pulled the ASR XL […]
Metal-on-Metal
Johnson & Johnson lawyers deny tampering allegations in hip case
Lawyers for Johnson & Johnson(NYSE:JNJ) in a bellwether trial over metal-on-metal hip implants made by J&J subsidiary DePuy Orthopaedics yesterday denied witness tampering allegations leveled by the lead plaintiff’s attorney. Last week a federal judge in Texas took the unusual step of asking federal prosecutors and the FBI to probe the possible witness tampering. Mark Lanier, lead attorney […]
Tampering allegations in Johnson & Johnson hip case prompt judge to trigger probe
A federal judge in Texas this week took the unusual step of asking federal prosecutors and the FBI to probe possible witness tampering by lawyers for Johnson & Johnson (NYSE:JNJ) in a bellwether trial over metal-on-metal hip implants made by J&J subsidiary DePuy Orthopaedics. Mark Lanier, lead attorney for the plaintiffs in one of six […]
J&J loses bid to stay FCA verdict
Earlier this week, the U.S. First Circuit Court of Appeals denied Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopedics’ bid to stay a decision reviving a False Claims Act suit over its allegedly faulty hip implants. Just days ago, the company urged the court to stay its decision while it appeals to the U.S. Supreme Court. The False […]
Stryker hits enrollment milestone in 2nd metal-on-metal hip implant settlement
Stryker (NYSE:SYK) said today that it hit a milestone in the 2nd round of settlements for the Rejuvenate or ABG II modular metal-on-metal neck hip stems made by its Howmedica Osteonics subsidiary, with 95% of eligible patients enrolled. The December 2016 agreement followed an earlier, $1 billion settlement over the implants, which were recalled in July 2012. […]
Failure to thrive: Lessons learned from medtech innovations that missed the mark
Some of the medical device industry’s most heralded disruptors wound up being its biggest failures. Here’s what we can learn from their mistakes. Fink Densford, Associate Editor No one in medtech sets out to fail. No one invests in building a device believing that, despite years of research and development, it won’t make the cut. […]
Johnson & Johnson seeks new trials after $1B Pinnacle hip implant loss
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics wants a federal judge to grant new trials after it lost a $1 billion judgment to 6 plaintiffs who sued over its metal-on-metal Pinnacle hip implant. A Dallas jury in December found that the metal-on-metal pinnacle hip implants were designed defectively and that the companies failed to appropriately warn patients of the […]
Stryker Q4 earnings take hit from recalled hip implants
Stryker’s profits decreased 2.3% year-over-year in the fourth quarter, to $510 million, amid charges related to its recalled Rejuvenate or ABG II modular metal-on-metal neck hip stems, as well as expenses related to restructuring and acquisition costs. Earnings per share were $1.34, down 2.9% year-over-year, the company reported Tuesday evening. Excluding the charges, Stryker’s profits would […]
Stryker reaches new metal-on-metal hip implant settlement deal
Stryker (NYSE:SYK) said today that it, and its Howmedica Osteonics subsidiary have reached a compensation agreement for patients who had revision surgery to correct issues with its recalled Rejuvenate or ABG II modular metal-on-metal neck hip stems. The agreement was reached by Court-appointed committees and attorneys for both Stryker and patients who received the metal-on-metal […]
Jury levels $1B verdict against J&J’s DePuy Ortho in Pinnacle hip bellwether
UPDATED Dec. 2, 2016, with quotes from plaintiff’s and defense attorneys and DePuy Orthopedics. A federal jury in Dallas today ordered Johnson & Johnson (NYSE:JNJ) and its subsidiary DePuy Orthopedics to pay more than $1 billion to 6 plaintiffs claiming to be injured by its Pinnacle metal-on-metal hip implants, according to the plaintiffs lawyers. Jurors in […]
Plaintiff’s $8m win in DePuy ASR hip trial survives Johnson & Johnson’s appeal
An $8 million plaintiff’s award in a product liability lawsuit brought over the DePuy ASR XL metal-on-metal hip implant made by Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics survived the company’s appeal to a California state court. The trial was the 1st of thousands of product liability cases filed over the ASR hip. Plaintiff Loren Kransky claimed that his […]